Bills · HR 4573
IN COMMITTEE· 119TH CONGRESS
House BillHR 4573Taxation
Innovate to Save Lives Act
INTRO JUL 21· LAST ACTION JUL 21
READING
4MIN
COSPONSORS
5BIPARTISAN
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenThis bill matters because it seeks to accelerate the development of solutions for some of the most pressing drug crises facing the nation, particularly those related to opioids like fentanyl and stimulants like methamphetamine. By offering a tax credit, the government is trying to encourage private small businesses to invest their resources into finding new ways to prevent drug use, treat addiction, or lessen the harm caused by these substances.
If this bill becomes law, it could lead to more innovation in areas like overdose reversal medications, addiction therapies, or prevention strategies. Without it, small businesses might have less incentive to undertake this often costly and risky research, potentially slowing down the discovery of new tools to combat these public health emergencies. Voters should care because the effectiveness of such incentives could directly impact the availability of solutions to drug-related problems in their communities.
KEY PROVISIONS
4AI-extractedPROVISION 01
Creates a new 10% tax credit for small businesses that conduct qualified research related to mitigating certain drug threats.
This provides a direct financial incentive for small businesses to invest in research addressing critical drug problems.
PROVISION 02
Defines 'qualified drug threat mitigation research' to include efforts to mitigate, treat, prevent, divert, or intervene in the use of specified drugs.
This clarifies the types of research activities that are eligible for the tax credit, focusing on a broad range of solutions.
PROVISION 03
Identifies 'specified drugs' as fentanyl, fentanyl-related substances, methamphetamine, and any 'emerging drug' designated by the Office of National Drug Control Policy.
This targets the tax credit to research efforts addressing some of the most dangerous and prevalent drug threats.
PROVISION 04
Requires the Government Accountability Office (GAO) to submit a report five years after enactment on the tax credits claimed and the types of research supported.
This ensures an evaluation of the program's effectiveness and transparency regarding its impact on drug threat mitigation research.
SPONSORSHIP
1 + 5
D· Colorado
YRS IN OFFICE
7
BILLS LED
92
COSPONSOR BREAKDOWNBIPARTISAN · 80%
DEM 2 REP 3 IND 0
ACTION TIMELINE
2 EVENTSJUL 21
Introduced in House
JUL 21
Referred to the House Committee on Ways and Means.
BILL INFO
TypeHouse Bill
NumberHR 4573
Congress119th
StatusIn Committee
IntroducedJul 21, 2025
Last actionJul 21, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · WAYS AND MEANS COMMITTEE · INTRODUCED JUL 21, 2025
House BillHR 4573Taxation
Innovate to Save Lives Act
INTRODUCED JUL 21, 2025· LAST ACTION JUL 21, 2025
PASSAGE CHANCES
—%
READING
4 min
COSPONSORS
5
COMPLEXITY
Moderate
